IL-22 exacerbates the severity of CVB3-induced acute viral myocarditis in IL-17A-deficient mice

Molecular Medicine Reports

Volumn 7, Issue 4, 2013, Pages 1329-1335

  Kong, Qing ^a   Xue, Yimin ^a   Wu, Weifeng ^a   Yang, Fan ^a   Liu, Yanli ^a   Gao, Mengsha ^a   Lai, Wenyin ^a   Pan, Xiaofen ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Acute viral myocarditis; Anti inflammatory; Antiviral; Interleukin 17A; Interleukin 22; Proinflammatory

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 17; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; HEART WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; SPLEEN LYMPHOCYTE; VIRUS MYOCARDITIS; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; HEART; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MICE; MYOCARDITIS; VIRUS REPLICATION;

EID: 84875265459     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1323     Document Type: Article

References (35)

1. Dennert R, Crijns HJ and Heymans S: Acute viral myocarditis. Eur Heart J 29: 2073-2082, 2008.
2. Gupta S, Markham DW, Drazner MH and Mammen PP: Fulminant myocarditis. Nat Clin Pract Cardiovasc Med 5: 693-706, 2008.
3. Cooper LT Jr: Myocarditis. N Engl J Med 360: 1526-1538, 2009.
4. Fairweather D and Rose NR: Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118-122, 2007.
5. Yuan J, Yu M, Lin QW, Cao AL, Yu X, Dong JH, Wang JP, Zhang JH, Wang M, Guo HP, Cheng X and Liao YH: Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. J Immunol 185: 4004-4010, 2010.
6. Yang F, Wu WF, Yan YL, Pang Y, Kong Q and Huang YL: Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis. Virol J 8: 301, 2011.
7. Trifari S, Kaplan CD, Tran EH, Crellin NK and Spits H: Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-871, 2009.
8. Sonnenberg GF, Fouser LA and Artis D: Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383-390, 2011.
9. Radaeva S, Sun R, Pan HN, Hong F and Gao B: Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342, 2004.
10. Ziesché E, Bachmann M, Kleinert H, Pfeilschifter J and Mühl H: The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 282: 16006-16015, 2007.
11. Takahashi K, Hirose K, Kawashima S, Niwa Y, Wakashin H, Iwata A, Tokoyoda K, Renauld JC, Iwamoto I, Nakayama T and Nakajima H: IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J Allergy Clin Immunol 128: 1067-1076, 2011.
12. Wang P, Bai F, Zenewicz LA, Dai J, Gate D, Cheng G, Yang L, Qian F, Yuan X, Montgomery RR, Flavell RA, Town T and Fikrig E: IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One 7: e44153, 2012.
13. Missé D, Yssel H, Trabattoni D, Oblet C, Lo Caputo S, Mazzotta F, Pène J, Gonzalez JP, Clerici M and Veas F: IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol 178: 407-415, 2007.
14. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M and Flavell RA: Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659, 2007.
15. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W Jr, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C and Flavell RA: IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491: 259-263, 2012.
16. Laurence A, O'Shea JJ and Watford WT: Interleukin-22: a sheep in wolf's clothing. Nat Med 14: 247-249, 2008.
17. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA and Artis D: Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 207: 1293-1305, 2010.
18. Kong Q, Wu W, Yang F, Liu Y, Xue Y, Gao M, Lai W, Pan X, Yan Y, Pang Y and Deng Y: Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis. Virol J 9: 232, 2012.
19. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M and Iwakura Y: Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387, 2002.
20. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M and Penninger JM: Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9: 1484-1490, 2003.
21. Stange J, Hepworth MR, Rausch S, Zajic L, Kühl AA, Uyttenhove C, Renauld JC, Hartmann S and Lucius R: IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology. J Immunol 188: 2410-2418, 2012.
22. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M and Fouser LA: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279, 2006.
23. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y and Kolls JK: IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281, 2008.
24. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, Collins M, Goldman SJ, Dunussi-Joannopoulos K, Williams CM, Wright JF and Fouser LA: An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179: 7791-7799, 2007.
25. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI and Spriggs MK: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821, 1995.
26. Gaffen SL: Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567, 2009.
27. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K and Iwakura Y: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177: 566-573, 2006.
28. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R and Haura EB: Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408, 2005.
29. Bollrath J and Greten FR: IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10: 1314-1319, 2009.
30. Fairweather D, Stafford KA and Sung YK: Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol 24: 401-407, 2012.
31. Woodruff JF and Woodruff JJ: Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J Immunol 113: 1726-1734, 1974.
32. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A and Sallusto F: Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863, 2009.
33. O'Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK and Flavell RA: A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10: 603-609, 2009.
34. Smith E, Stark MA, Zarbock A, Burcin TL, Bruce AC, Vaswani D, Foley P and Ley K: IL-17A inhibits the expansion of IL-17A-producing T cells in mice through 'short-loop' inhibition via IL-17 receptor. J Immunol 181: 1357-1364, 2008.
35. von Vietinghoff S and Ley K: IL-17A controls IL-17F production and maintains blood neutrophil counts in mice. J Immunol 183: 865-873, 2009.